Processa Pharmaceuticals, Inc. — Director's Dealing 2023

Aug 9, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Processa Pharmaceuticals, Inc. (PCSA)
CIK: 0001533743
Period of Report: 2023-08-08

Reporting Person: Ng George K (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-08-08	Restricted Stock Units	$0	A	400000	Acquired		Common Stock (400000)	Direct
2023-08-08	Restricted Stock Units	$0	A	400000	Acquired		Common Stock (400000)	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting of one-third on 08/08/24, 08/08/25, and 08/08/26 or upon a change in control event.

F2: The restricted stock units vest upon the achievement of certain performance goals.